Aussie8 – Lifestyle
Author:
Trevi Therapeutics, Inc.
Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough
March 9, 2026
←
Previous Page
1
2